Infant Bacterial Therapeutics AB (IFTBF)
6.85
0.00 (0.00%)
USD |
OTCM |
Oct 08, 16:00
Infant Bacterial Therapeutics Net Income (Quarterly) : -3.175M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.175M |
| March 31, 2026 | -2.509M |
| December 31, 2025 | -2.041M |
| September 30, 2025 | -1.056M |
| June 30, 2025 | -1.983M |
| March 31, 2025 | -1.568M |
| December 31, 2024 | -3.132M |
| September 30, 2024 | -3.133M |
| June 30, 2024 | -3.992M |
| March 31, 2024 | -2.676M |
| December 31, 2023 | -3.832M |
| September 30, 2023 | -2.857M |
| June 30, 2023 | -2.735M |
| March 31, 2023 | -2.152M |
| December 31, 2022 | -3.738M |
| September 30, 2022 | -0.7379M |
| June 30, 2022 | 0.1676M |
| March 31, 2022 | -2.056M |
| December 31, 2021 | -1.83M |
| Date | Value |
|---|---|
| September 30, 2021 | -0.0067M |
| June 30, 2021 | -3.463M |
| March 31, 2021 | 0.0537M |
| December 31, 2020 | -3.103M |
| September 30, 2020 | -2.096M |
| June 30, 2020 | -2.884M |
| March 31, 2020 | 0.1217M |
| December 31, 2019 | -2.863M |
| September 30, 2019 | -1.099M |
| June 30, 2019 | -0.8007M |
| March 31, 2019 | -0.0748M |
| December 31, 2018 | -2.669M |
| September 30, 2018 | -0.8925M |
| June 30, 2018 | 0.0766M |
| March 31, 2018 | -1.127M |
| December 31, 2017 | -1.089M |
| September 30, 2017 | -0.5629M |
| June 30, 2017 | -1.571M |
| March 31, 2017 | -0.9599M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Orexo AB | -10.95M |
| Swedencare AB | 2.531M |
| Camurus AB | 25.72M |
| Moberg Pharma AB | -0.3504M |
| AstraZeneca PLC | 3.076B |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 3.175M |
| EPS Diluted (Quarterly) | -0.2357 |
| Enterprise Value | 81.06M |
| Earnings Yield | -9.52% |
| Normalized Earnings Yield | -9.515 |